Search Results - "Kya Jai Maug, Aung"

Injectables’ key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes by Decroo, Tom, Maug, Aung Kya Jai, Hossain, Mohamed Anwar, Uwizeye, Cecile, Gumusboga, Mourad, Demeulenaere, Tine, Ortuno-Gutierrez, Nimer, de Jong, Bouke C, Van Deun, Armand

“…Background Since a meta-analysis showed little or no effect of second-line injectables on treatment success, and using injectables may induce ototoxicity,…”
Get full text

The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance by Van Deun, Armand, Decroo, Tom, Kya Jai Maug, Aung, Hossain, Mohamed Anwar, Gumusboga, Murid, Mulders, Wim, Ortuño-Gutiérrez, Nimer, Lynen, Lutgarde, de Jong, Bouke C, Rieder, Hans L

“…Meta-analyses on impact of isoniazid-resistant tuberculosis informed the World Health Organization recommendation of a levofloxacin-strengthened…”
Get full text

Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis by Van Deun, Armand, Maug, Aung Kya Jai, Salim, Md Abdul Hamid, Das, Pankaj Kumar, Sarker, Mihir Ranjan, Daru, Paul, Rieder, Hans L

“…Based on expert opinion, the global guidelines for management of multidrug-resistant tuberculosis impose lengthy and often poorly tolerated treatments. This…”
Get full text

Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis by Abidi, Syed, Achar, Jay, Assao Neino, Mourtala Mohamed, Bang, Didi, Benedetti, Andrea, Brode, Sarah, Campbell, Jonathon R, Casas, Esther C, Conradie, Francesca, Dravniece, Gunta, du Cros, Philipp, Falzon, Dennis, Jaramillo, Ernesto, Kuaban, Christopher, Lan, Zhiyi, Lange, Christoph, Li, Pei Zhi, Makhmudova, Mavluda, Maug, Aung Kya Jai, Menzies, Dick, Migliori, Giovanni Battista, Miller, Ann, Myrzaliev, Bakyt, Ndjeka, Norbert, Noeske, Jürgen, Parpieva, Nargiza, Piubello, Alberto, Schwoebel, Valérie, Sikhondze, Welile, Singla, Rupak, Souleymane, Mahamadou Bassirou, Trébucq, Arnaud, Van Deun, Armand, Viney, Kerri, Weyer, Karin, Zhang, Betty Jingxuan, Ahmad Khan, Faiz

“…We sought to compare the effectiveness of two World Health Organization (WHO)-recommended regimens for the treatment of rifampin- or multidrug-resistant…”
Get full text

Levels of disability and relapse in Bangladeshi MB leprosy cases, 10 years after treatment with 6m MB-MDT by Butlin, C. Ruth, Aung, Kya Jai Maug, Withington, Stephen, Nicholls, Peter, Alam, Khorshed

“…Introduction: Since 1998 the recommended duration of treatment for multi-bacillary (MB) leprosy cases has been 12 months. Further shortening the duration of…”
Get full text

Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown by Van Deun, Armand, Decroo, Tom, Aung, Kya Jai Maug, Hossain, Mohamed Anwar, Gumusboga, Mourad, De Rijk, Willem Bram, Tahseen, Sabira, de Jong, Bouke Catherine, Rigouts, Leen

Get full text

Bedaquiline can act as core drug in a standardised treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis by Decroo, Tom, Aung, Kya Jai Maug, Hossain, Mohamed Anwar, Gumusboga, Mourad, Ortuno-Gutierrez, Nimer, De Jong, Bouke Catherine, Van Deun, Armand

“…In Bangladesh, a standardised short treatment regimen (STR) was highly effective in patients diagnosed with rifampicin-resistant tuberculosis (RR-TB), without…”
Get full text

Molecular characterization and drug susceptibility profile of Mycobacterium tuberculosis isolates from Northeast Bangladesh by Uddin, Mohammad Khaja Mafij, Ahmed, Moshtaq, Islam, Mohammad Riazul, Rahman, Arfatur, Khatun, Razia, Hossain, Mohammad Anwar, Maug, Aung Kya Jai, Banu, Sayera

“…Tuberculosis (TB) remains a major public health problem worldwide including in Bangladesh. Molecular epidemiological tools provide genotyping profiles of…”
Get full text

Outcome of 6 months MBMDT in MB patients in Bangladesh- preliminary results by Butlin, C Ruth, Pahan, David, Maug, Aung Kya Jai, Withington, Stephen, Nicholls, Peter, Alam, Khorshed, Salim, M D Abdul Hamid

“…Duration of leprosy treatment remains long and difficult to complete in resource poor areas. Studies suggest that shortening duration of therapy for MB…”
Get full text